Showing results (1421-1430 of 1,543) with videos related to

Sort By:
Pageof 155
British Journal of Cancer|May 4, 2023
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trialMakoto Yamasaki, Hiroshi Miyata, Kotaro Yamashita, et al.
Critical Care Medicine|November 16, 2023
Evaluation of the Impact of ABCDEF Bundle Compliance Rates on Postintensive Care Syndrome: A Secondary Analysis StudyDaisuke Kawakami, Shigeki Fujitani, Hidenobu Koga, et al.
Endocrinology|June 14, 2023
Protective Effects of Imeglimin and Metformin Combination Therapy on β-Cells in db/db Male MiceKuniyuki Nishiyama, Masato Ono, Takahiro Tsuno, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 1, 2021
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational studyYuichi Ito, Kazumasa Fujitani, Kentaro Sakamaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 14, 2011
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysisKohei Shitara, Satoshi Morita, Kazumasa Fujitani, et al.
Annals of Gastroenterological Surgery|February 3, 2021
Long-term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5-fluorouracil vs docetaxel, cisplatin, and 5-fluorouracil followed by surgery for esophageal cancer (OGSG1003)Keijiro Sugimura, Makoto Yamasaki, Takushi Yasuda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|March 19, 2021
Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trialOsamu Shiraishi, Tomoki Makino, Makoto Yamasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Analysis of patients with gastrointestinal neuroendocrine tumor]Junji Kawada, Masashige Nishimura, Yuki Matsui, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2015
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialKazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, et al.
Patient Education and Counseling|July 17, 2024
Differences in code status practice patterns among emergency clinicians working in Japan and the United StatesKenji Numata, Shigeki Fujitani, Hiraku Funakoshi, et al.
Pageof 155